Clinical Trials Logo

Filter by:
NCT ID: NCT04279873 Completed - Clinical trials for Nosocomial Pneumonia

Use of Microscopy, Cultures and Molecular Biological Methods for Diagnosing Nosocomial Pneumonia

Start date: May 1, 2014
Phase:
Study type: Observational

Nosocomial pneumonia in the Intensive Care Unit is often not properly diagnosed mainly due to ongoing antimicrobial therapy. The study investigates the feasibility of more advanced diagnostic technics.

NCT ID: NCT04279366 Completed - Healthy Aging Clinical Trials

Biological Age Applied at Ubberup

Start date: November 15, 2020
Phase:
Study type: Observational [Patient Registry]

In a previous study the investigators have developed a novel biological age model. Assessing biological age is the assessment of the present health status and functional capacity/physiological reserve of that person in comparison with people of the same age and sex. The aim of this study is to investigate the utility and validity of this novel biological age model designed for health promotion in real world conditions.

NCT ID: NCT04278001 Completed - Clinical trials for Arterial Hypertension

Clinical Usefullness of the Cuffless SOMNOtouch NIBP Device for 24-hour Ambulatory Blood Pressure Measurement

BLAST
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The SOMNOtouch NIBP is a cuffless device for continuous blood pressure measurement. The device is widely used, but validation for 24-hour ambulatory blood pressure measurement (ABPM) is limited. This study seeks to validate the SOMNOtouch device for use in 24-hour ABMP as compared to a validated oscillometric device for 24-hour ABPM. A total of 60 patients with indication for 24-hour BP measurement will be recruited from our tertiary hypertension Clinic. All included patients will conduct dual 24-hour ABPM with both the SOMNOtouch NIBP and a the oscillometric device. Furthermore, patients will undergo measurement of arterial stiffness with a Sphygmocor device as well as complete a questionaire on device related discomfort.

NCT ID: NCT04274842 Completed - Telangiectasia Clinical Trials

D-OCT of Facial Telangiectasia Treated With IPL

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Objectives: To examine whether dynamic Optical Coherence Tomography (OCT) could characterize vessel dimensions and blood flow of telangiectasias before and after treatment with Intense Pulsed Light (IPL). Methods: Dynamic-OCT (D-OCT) imaged telangiectasia characterized blood vessel width and depth, blood flow, and attenuation. Measurements were done immediately before and after, 1-3 days after, and 1 month after IPL treatment. Characterization of vessel dimensions at baseline were verified by a blinded observer. At one-month follow-up, clinical improvement was characterized as good, moderate or none and possible adverse effects were described.

NCT ID: NCT04273490 Completed - Clinical trials for X-linked Hypophosphatemia

Characterising Pain, QoL, Body Composition, Arterial Stiffness, Muscles and Bones in Adult Persons With XLH and Healthy Controls

Start date: February 18, 2020
Phase:
Study type: Observational

Hereditary hypophosphatemia (XLH) is a rare, inherited disease. Loss-of-function mutation in the phosphate regulating gene with homologies to endopeptidases on the X-chromosome (PHEX) results in excess fibroblast growth factor 23 (FGF23) production and manifests as rickets in children and osteomalacia in adults. This study aims to characterize and measure pain, quality of life, muscle function, body composition, arterial stiffness, bone mineral density, geometry and microarchitecture in patients with XLH compared to age and gender-matched controls.

NCT ID: NCT04271280 Completed - Clinical trials for Cardiovascular Diseases

Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events

SANTORINI
Start date: March 17, 2020
Phase:
Study type: Observational

High and Very High Risk cardiovascular patient journeys seems to vary from country to country, and current understanding of the process is incomplete. This real-life observational study which documents meaningful patient journey-related parameters can be expected to provide meaningful insight into the care process, country-by-country.

NCT ID: NCT04270877 Completed - Fibromyalgia Clinical Trials

Fibromyalgia and Naltrexone: The FINAL Study

FINAL
Start date: January 6, 2021
Phase: Phase 2
Study type: Interventional

This study evaluates the effect of low dose naltrexone (LDN) on pain in women with fibromyalgia (FM). The study is designed as a parallel randomized (1:1) double blind, placebo-controlled superiority trial. Half of the participants will receive treatment with LDN while the other half will receive treatment with placebo.

NCT ID: NCT04270760 Completed - Clinical trials for Cardiovascular Disease

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Start date: July 28, 2020
Phase: Phase 2
Study type: Interventional

Evaluate the effect of olpasiran administered subcutaneously (SC) compared with placebo, on percent change from baseline in lipoprotein(a) (Lp[a]).

NCT ID: NCT04269733 Completed - Clinical trials for Atrioventricular Block

Risk of Pacing-induced Cardiomyopathy

Start date: May 1, 2020
Phase:
Study type: Observational

This study will evaluate the association between right ventricular pacing and the risk of pacing-induced cardiomyopathy.

NCT ID: NCT04266639 Completed - Ischemic Stroke Clinical Trials

Rheo-Erythrocrine Dysfunction as a Biomarker for RIC Treatment in Acute Ischemic Stroke

ENOS
Start date: July 29, 2020
Phase: N/A
Study type: Interventional

This study aims to investigate whether Remote Ischemic Conditioning (RIC) improves rheo-erythrocrine dysfunction in acute ischemic stroke